[Form 4] Fabrinet Insider Trading Activity

Rhea-AI Filing Summary

Fabrinet (FN) insider sale reported by Csaba Sverha, Chief Financial Officer. The Form 4 shows two sales on 08/28/2025: 7,981 ordinary shares sold at a weighted average price of $349.594 (range $349.01–$349.95) and 5,019 ordinary shares sold at a weighted average price of $350.275 (range $350.02–$350.73). The filing lists post-transaction beneficial ownership figures of 13,571 and 8,552 shares respectively. The Form 4 was submitted by Andrew Chew as attorney-in-fact on 08/29/2025. Explanations note the reported prices are weighted averages and that the reporting person will provide detailed per-price sale counts upon request.

Positive

• Timely disclosure: The Form 4 was filed promptly and includes weighted-average price ranges and post-transaction ownership counts.
• Compliance detail: The filing offers to provide per-price sale counts upon request, aiding transparency.

Negative

• Insider selling: The CFO sold a total of 13,000 shares on 08/28/2025, which could be viewed negatively by some investors.
• No stated reason: The filing does not disclose whether the sales were part of a pre-arranged plan or routine liquidity needs.

Insights

Financial Analyst

TL;DR: Significant insider stock sales by the CFO were disclosed; transactions are routine but worth noting for share supply effects.

The filing records two block sales totaling 13,000 shares executed on 08/28/2025 at weighted average prices around $349.59 and $350.28. The disclosure includes weighted-average price ranges and post-sale beneficial ownership counts. From a liquidity perspective, 13,000 shares sold by a senior officer can modestly increase available float in the short term. No additional context on reason, planned disposition, or Rule 10b5-1 plan is provided in the filing, so valuation or tax-motivated explanations cannot be assessed from this document alone.

Corporate Governance Expert

TL;DR: The CFO executed reported sales and the Form 4 contains required weighted-average price disclosure; no governance concerns explicitly stated.

The Form 4 identifies Csaba Sverha as the reporting officer and shows two separate sales with specified weighted-average price ranges. The filing includes a standard offer to provide per-price sale details on request and is signed by an attorney-in-fact. The submission appears to comply with Section 16 reporting requirements; it does not indicate any exception, Rule 10b5-1 plan, or other governance-related disclosures within this document.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sverha Csaba

(Last) (First) (Middle)

C/O FABRINET USA, INC.

3736 FALLON ROAD #428

(Street)

DUBLIN CA 94568

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fabrinet [ FN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/28/2025		S		7,981	D	$349.594(1)	13,571	D
Ordinary Shares	08/28/2025		S		5,019	D	$350.275(2)	8,552	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale price represents the weighted average sale price of the shares sold ranging from $349.01 to $349.95 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

2. This sale price represents the weighted average sale price of the shares sold ranging from $350.02 to $350.73 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	Andrew Chew, Attorney-in-fact for Csaba Sverha	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Fabrinet (FN) insider Csaba Sverha report on Form 4?

Answer: The CFO reported two sales on 08/28/2025 totaling 13,000 ordinary shares at weighted average prices of $349.594 and $350.275, with post-transaction beneficial ownership figures shown.

When were the transactions reported for FN insider activity?

Answer: Transactions occurred on 08/28/2025 and the Form 4 was filed and signed by an attorney-in-fact on 08/29/2025.

How many shares did the reporting person sell and at what prices?

Answer: Sold 7,981 shares at a weighted average of $349.594 (range $349.01–$349.95) and 5,019 shares at a weighted average of $350.275 (range $350.02–$350.73).

Does the Form 4 state a Rule 10b5-1 trading plan or reason for sale?

Answer: The filing does not state that the sales were pursuant to a Rule 10b5-1 plan nor provide a reason for the transactions.

Who signed or filed the Form 4 for Csaba Sverha?

Answer: The Form 4 is signed and filed by Andrew Chew as attorney-in-fact for Csaba Sverha on 08/29/2025.